PLSE - CIK 0001625101
Pulse Biosciences, Inc. (PLSE) reported net income of -$72.78M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$72.78M | -35.8% |
| FY 2024 | -$53.59M | -26.9% |
| FY 2023 | -$42.21M | +27.9% |
| FY 2022 | -$58.51M | +8.1% |
| FY 2021 | -$63.66M | -27.7% |
| FY 2020 | -$49.85M | -6.1% |
| FY 2019 | -$46.97M | -25.1% |
| FY 2018 | -$37.55M | -46.8% |
| FY 2017 |
Pulse Biosciences, Inc. (PLSE) reported net income of -$72.78M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2015 and fiscal 2025, Pulse Biosciences, Inc.'s net income declined from -$2.81M to -$72.78M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| -$25.57M |
| -168.6% |
| FY 2016 | -$9.52M | -238.6% |
| FY 2015 | -$2.81M | - |